Table 2 Patients treated with second/further-line HDIFX chemotherapy: clinical characteristics and response evaluation
Patients ID | Gender | Age at time of diagnosis (years) | Myxofibrosarcoma grade | Site of primary tumour | Site of relapse at time of CT | Response evaluation criteria in solid tumours (RECIST) evaluation |
|---|---|---|---|---|---|---|
1 | F | 62 | 3 | Groin | Abdomen | PD |
2 | F | 43 | 3 | Right arm | Lung | PD |
3 | M | 71 | 2 | Left thigh | Lung | PR |
4 | M | 54 | 2 | Left thigh | Lung | PR |
5 | F | 72 | 2 | Right arm | Local relapse | SD |
6 | M | 46 | 3 | Thoracic wall | Local relapse | RC |
7 | F | 60 | 3 | Right arm | Lung | PD |
8 | M | 74 | 2 | Left thigh | Lung | PD |
9 | M | 57 | 1 | Groin | Local relapse | PR |
10 | F | 33 | 3 | Abdomen | Lung and abdomen | PR |
11 | M | 34 | 3 | Right thigh | Lung | PD |
12 | M | 71 | 3 | Right arm | Lung | PR |
13 | M | 70 | 1 | sex cord | Local relapse | PR |
14 | F | 48 | 1 | Left thigh | Local relapse | SD |
15 | M | 51 | 2 | Left thigh | Lung | PD |
16 | F | 27 | 2 | Abdomen | Abdomen | SD |
17 | M | 67 | 1 | Left thigh | Local relapse | PD |
18 | M | 56 | 2 | Thoracic wall | Lung | PD |
19 | F | 44 | 3 | Right thigh | Local relapse | PD |
20 | M | 51 | 3 | Left leg | Lung | PR |
21 | M | 64 | 2 | Abdomen | Lung | PD |
22 | F | 75 | 2 | Right arm | Local relapse | PR |
23 | M | 50 | 1 | Right thigh | Local relapse | PR |
24 | M | 65 | 2 | Left thigh | Lung | PD |
25 | M | 58 | 3 | Left arm | Lung | PD |
26 | F | 33 | 3 | Left thigh | Lung and abdomen | PD |
27 | F | 50 | 1 | Thoracic wall | Lung and abdomen | SD |
28 | M | 51 | 3 | Left thigh | Lung | PD |